Empowering life scientists globally with high-quality biological reagents and tools critical to research, drug discovery and diagnostics

Press Release

Abcam appoints Markus Lusser as new President

Press Release

Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting

Press Release

Abcam most cited antibody supplier for IHC in 2023

Press Release

Interim results for the six-month period ended 30 June 2023

Press Release

Danaher to acquire Abcam for $24.00 per Share

Press Release

Lunaphore and abcam announce agreement for primary antibody validation for use on COMET™

Stay up to date with Abcam

NEWS

Keep up to date with our company news

Sign-up to receive the latest corporate updates from Abcam.

EVENTS

Get information on events we are organizing and attending

Including Abcam conferences and webinars.